Clinical trialNCT02836873CompletedPhase 3Interventional

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

SponsorTheracosEnrollment312Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew Allegretti, M.D.
Massachusetts General Hospital
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France

Research Site
Dijon, France
Research Site
Paris, France
Research Site
Paris, France
Research Site
Paris, France
Research Site
Pierre-Bénite, France
Research Site
Poitiers, France
Research Site
Vénissieux, France

Japan

Research Site
Atsugi-shi, Kanagawa, Japan
Research Site
Kamakura-shi, Kanagawa, Japan
Research Site
Kawasaki-shi, Kanagawa, Japan
Research Site
Yokohama, Kanagawa, Japan
Research Site
Yokohama, Kanagawa, Japan
Research Site
Yokohama, Kanagawa, Japan
Research Site
Kyoto, Kyoto, Japan
Research Site
Kyoto, Kyoto, Japan
Research Site
Kawagoe-shi, Saitama, Japan
Research Site
Kawaguchi-shi, Saitama, Japan
Research Site
Sayama-shi, Saitama, Japan
Research Site
Hachioji-shi, Tokyo, Japan
Research Site
Hachioji-shi, Tokyo, Japan
Research Site
Minato-ku, Tokyo, Japan
Research Site
Shinagawa-ku, Tokyo, Japan
Research Site
Ōta-ku, Tokyo, Japan
Research Site
Toshima-ku, Toyko, Japan

Spain

Research Site
Alcalá de Henares, Spain
Research Site
Alicante, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Málaga, Spain
Research Site
Seville, Spain
Research Site
Valencia, Spain
Research Site
Valencia, Spain

United States

Research Site
Fresno, California, United States
Research Site
La Palma, California, United States
Research Site
Lincoln, California, United States
Research Site
Riverside, California, United States
Research Site
Sacramento, California, United States
Research Site
San Dimas, California, United States
Research Site
Monument, Colorado, United States

16 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 23 Sept 2016
Primary completion: 11 Jan 2018
Completion: 11 Jan 2018
Last update posted: 30 Jun 2021
Registered enrollment: 312
Registry id: NCT02836873

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.